wellrank.ai
Sign In

How much is Ozempic per month without insurance and how do people afford it?

ClaudepricingCollected Sep 10, 2026, 15:14 UTC

Verbatim response from Claude

Ozempic Cost Without Insurance

Retail price: approximately $900–$1,000+ per month for a typical dose. It's quite expensive.


How People Afford It

Manufacturer Savings Programs:

  • Novo Nordisk's Ozempic Savings Card – eligible commercially insured patients may pay as little as $25/month, but this doesn't help the uninsured

Discount Programs:

  • GoodRx – can bring cost down to roughly $800–$950 (modest savings)
  • Cost Plus Drugs (Mark Cuban's pharmacy) – check their site, though Ozempic availability varies
  • NeedyMeds.org – helps find patient assistance programs

Compounded/Alternative Options:

  • Compounding pharmacies (through telehealth services like Hims/Hers, LifeMD, or Ro) have offered compounded semaglutide for $200–$400/month – though the FDA has been cracking down on this
  • Rybelsus (oral semaglutide, same drug) sometimes has different pricing

Insurance Route:

  • Getting a type 2 diabetes diagnosis (vs. weight loss) significantly improves coverage chances
  • Appealing insurance denials with doctor support

Patient Assistance:

  • Novo Nordisk Patient Assistance Program for low-income patients – potentially free

Would you like more detail on any of these options?

Brands mentioned in this answer

More Ozempic answers

See all Ozempic rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.